Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2021

Open Access 01-12-2021 | Crohn's Disease | Research

From bowel inflammation to the bone and joints: musculoskeletal examination in inflammatory bowel disease (IBD)

Authors: Samane Tavassoli, Iman Shahabinasab, Alireza Norouzi, Taghi Amiriani, Nafiseh Abdolahi, Somayeh Livani, Seyed Farzam Mirkamali, Honey Sadat Mirkarimi, Fazel Isapanah Amlashi, Sima Besharat

Published in: BMC Musculoskeletal Disorders | Issue 1/2021

Login to get access

Abstract

Background

One of the most important complications in inflammatory Bowel Disease (IBD) are musculoskeletal manifestations that are reported in more than 50% of patients.

Objectives

In this study, we aimed to evaluate the musculoskeletal and radiologic manifestations in our IBD patients.

Methods

In this cross-sectional study on 96 mild-to-moderate IBD patients (76 UC, 18 CD and 2 undifferentiated IBD) with mean (SD) age of 39.28 (11.42) years, 44 (45.8%) were males and 52 were (54.2%) females. Patients were examined by an expert rheumatologist and their musculoskeletal symptoms were assessed. The musculoskeletal system was evaluated by Modified Schober test, Thoracic expansion (TE), Occiput to wall distance (OWD), and Patrick’s or FABER test. Peripheral joints were also examined in all four extremities. Then patients were referred for pelvic and lumbosacral x-ray. Sacroiliitis grading was performed using the New York criteria.

Results

Inflammatory low back pain was reported in 5 (5.2%), enthesopathy in 6 (6.5%) and dactylitis in 1 (1.1%). Positive Schober test was recorded in 5 (5.2%) and Patrick test in 3 (3.1%). Forty-nine (51%) cases had normal imaging with no sacroiliitis, endplate sclerosis was seen in 33 cases (34.4%), grade 3 and grade 4 were seen in 10 cases (10.4%).

Conclusions

In the present study, 34.4% of the IBD patients had mild radiologic changes as endplate sclerosis and 95% had a normal physical examination.
Literature
1.
go back to reference Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369(9573):1627–40.CrossRef Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369(9573):1627–40.CrossRef
2.
go back to reference Triantafillidis JK, Merikas E, Georgopoulos F. Current and emerging drugs for the treatment of inflammatory bowel disease. Drug Des Dev Ther. 2011;5:185.CrossRef Triantafillidis JK, Merikas E, Georgopoulos F. Current and emerging drugs for the treatment of inflammatory bowel disease. Drug Des Dev Ther. 2011;5:185.CrossRef
3.
go back to reference Harbord M, Annese V, Vavricka SR, Allez M, Barreiro-de Acosta M, Boberg KM, et al. The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2016;10(3):239–54.CrossRef Harbord M, Annese V, Vavricka SR, Allez M, Barreiro-de Acosta M, Boberg KM, et al. The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2016;10(3):239–54.CrossRef
4.
go back to reference Cardoneanu A, Prelipcean CC, Danciu M, Mihai C, Dranga M, Gavrilescu O, et al. Looking beyond gut inflammation in inflammatory bowel. Romanian J Morphol Embryol. 2018;59(4):1097–105. Cardoneanu A, Prelipcean CC, Danciu M, Mihai C, Dranga M, Gavrilescu O, et al. Looking beyond gut inflammation in inflammatory bowel. Romanian J Morphol Embryol. 2018;59(4):1097–105.
5.
go back to reference Sarbu MI, Sarbu N. Musculoskeletal clinical and imaging manifestations in inflammatory bowel diseases. Open Med. 2019;14(1):75–84.CrossRef Sarbu MI, Sarbu N. Musculoskeletal clinical and imaging manifestations in inflammatory bowel diseases. Open Med. 2019;14(1):75–84.CrossRef
6.
go back to reference Zippi M, Corrado C, Pica R, Avallone EV, Cassieri C, De Nitto D, et al. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol. 2014;20(46):17463.CrossRef Zippi M, Corrado C, Pica R, Avallone EV, Cassieri C, De Nitto D, et al. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol. 2014;20(46):17463.CrossRef
7.
go back to reference Zochling J, Braun J, van der Heijde D. Assessments in ankylosing spondylitis. Best Pract Res Clin Rheumatol. 2006;20(3):521–37.CrossRef Zochling J, Braun J, van der Heijde D. Assessments in ankylosing spondylitis. Best Pract Res Clin Rheumatol. 2006;20(3):521–37.CrossRef
8.
go back to reference Assassi S, Weisman MH, Lee M, Savage L, Diekman L, Graham TA, et al. New population-based reference values for spinal mobility measures based on the 2009–2010 National Health and nutrition examination survey. Arthritis Rheumatol. 2014;66(9):2628–37.CrossRef Assassi S, Weisman MH, Lee M, Savage L, Diekman L, Graham TA, et al. New population-based reference values for spinal mobility measures based on the 2009–2010 National Health and nutrition examination survey. Arthritis Rheumatol. 2014;66(9):2628–37.CrossRef
9.
go back to reference Arvikar SL, Fisher MC. Inflammatory bowel disease associated arthropathy. Curr Rev Musculoskelet Med. 2011;4(3):123–31.CrossRef Arvikar SL, Fisher MC. Inflammatory bowel disease associated arthropathy. Curr Rev Musculoskelet Med. 2011;4(3):123–31.CrossRef
10.
11.
go back to reference Olpin JD, Sjoberg BP, Stilwill SE, Jensen LE, Rezvani M, Shaaban AM. Beyond the bowel: extraintestinal manifestations of inflammatory bowel disease. Radiographics. 2017;37(4):1135–60.CrossRef Olpin JD, Sjoberg BP, Stilwill SE, Jensen LE, Rezvani M, Shaaban AM. Beyond the bowel: extraintestinal manifestations of inflammatory bowel disease. Radiographics. 2017;37(4):1135–60.CrossRef
12.
go back to reference Aardoom MA, Veereman G, de Ridder L. A review on the use of anti-TNF in children and adolescents with inflammatory bowel disease. Int J Mol Sci. 2019;20(10):2529.CrossRef Aardoom MA, Veereman G, de Ridder L. A review on the use of anti-TNF in children and adolescents with inflammatory bowel disease. Int J Mol Sci. 2019;20(10):2529.CrossRef
13.
go back to reference Palazzi C, D’Angelo S, Gilio M, Leccese P, Padula A, Olivieri I. Pharmacological therapy of spondyloarthritis. Expert Opin Pharmacother. 2015;16(10):1495–504.CrossRef Palazzi C, D’Angelo S, Gilio M, Leccese P, Padula A, Olivieri I. Pharmacological therapy of spondyloarthritis. Expert Opin Pharmacother. 2015;16(10):1495–504.CrossRef
14.
go back to reference Pouillon L, Bossuyt P, Peyrin-Biroulet L. Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease. Expert Opin Biol Ther. 2016;16(10):1277–90.CrossRef Pouillon L, Bossuyt P, Peyrin-Biroulet L. Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease. Expert Opin Biol Ther. 2016;16(10):1277–90.CrossRef
15.
go back to reference Antonelli-Incalzi R, Pedone C, Cesari M, Di Iorio A, Bandinelli S, Ferrucci L. Relationship between the occiput-wall distance and physical performance in the elderly: a cross sectional study. Aging Clin Exp Res. 2007;19(3):207–12.CrossRef Antonelli-Incalzi R, Pedone C, Cesari M, Di Iorio A, Bandinelli S, Ferrucci L. Relationship between the occiput-wall distance and physical performance in the elderly: a cross sectional study. Aging Clin Exp Res. 2007;19(3):207–12.CrossRef
16.
go back to reference Linden SVD, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheum. 1984;27(4):361–8.CrossRef Linden SVD, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheum. 1984;27(4):361–8.CrossRef
17.
go back to reference Bennebroek Evertsz' F, Nieuwkerk PT, Stokkers PC, Ponsioen CY, Bockting CL, Sanderman R, et al. The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers. J Crohns Colitis. 2013;7(11):890–900.CrossRef Bennebroek Evertsz' F, Nieuwkerk PT, Stokkers PC, Ponsioen CY, Bockting CL, Sanderman R, et al. The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers. J Crohns Colitis. 2013;7(11):890–900.CrossRef
18.
go back to reference Callhoff J, Sieper J, Weiß A, Zink A, Listing J. Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis. Ann Rheum Dis. 2015;74(6):1241–8.CrossRef Callhoff J, Sieper J, Weiß A, Zink A, Listing J. Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis. Ann Rheum Dis. 2015;74(6):1241–8.CrossRef
19.
go back to reference Giani T, Bernardini A, Basile M, Di Maurizo M, Perrone A, Renzo S, et al. Usefulness of magnetic resonance enterography in detecting signs of sacroiliitis in young patients with inflammatory bowel disease. Pediatr Rheumatol. 2020;18:1–6.CrossRef Giani T, Bernardini A, Basile M, Di Maurizo M, Perrone A, Renzo S, et al. Usefulness of magnetic resonance enterography in detecting signs of sacroiliitis in young patients with inflammatory bowel disease. Pediatr Rheumatol. 2020;18:1–6.CrossRef
20.
go back to reference Chan J, Sari I, Salonen D, Silverberg MS, Haroon N, Inman RD. Prevalence of sacroiliitis in inflammatory bowel disease using a standardized computed tomography scoring system. Arthritis Care Res. 2018;70(5):807–10.CrossRef Chan J, Sari I, Salonen D, Silverberg MS, Haroon N, Inman RD. Prevalence of sacroiliitis in inflammatory bowel disease using a standardized computed tomography scoring system. Arthritis Care Res. 2018;70(5):807–10.CrossRef
21.
go back to reference Becciolini A, Di Donato E, Lucchini G, Santilli D, Mozzani F, Riva M, et al. Imaging in the assessment of musculoskeletal manifestations associated with inflammatory bowel disease. Gastroenterol Insights. 2021;12(1):100–10.CrossRef Becciolini A, Di Donato E, Lucchini G, Santilli D, Mozzani F, Riva M, et al. Imaging in the assessment of musculoskeletal manifestations associated with inflammatory bowel disease. Gastroenterol Insights. 2021;12(1):100–10.CrossRef
22.
go back to reference Fauny M, Cohen N, Morizot C, Leclerc-Jacob S, Wendling D, Lux G, et al. Low back pain and sacroiliitis on cross-sectional abdominal imaging for axial spondyloarthritis diagnosis in inflammatory bowel diseases. Inflamm Intest Dis. 2020;5(3):124–31.CrossRef Fauny M, Cohen N, Morizot C, Leclerc-Jacob S, Wendling D, Lux G, et al. Low back pain and sacroiliitis on cross-sectional abdominal imaging for axial spondyloarthritis diagnosis in inflammatory bowel diseases. Inflamm Intest Dis. 2020;5(3):124–31.CrossRef
23.
go back to reference Kelly OB, Li N, Smith M, Chan J, Inman RD, Silverberg MS. The prevalence and clinical associations of subclinical sacroiliitis in inflammatory bowel disease. Inflamm Bowel Dis. 2019;25(6):1066–71.CrossRef Kelly OB, Li N, Smith M, Chan J, Inman RD, Silverberg MS. The prevalence and clinical associations of subclinical sacroiliitis in inflammatory bowel disease. Inflamm Bowel Dis. 2019;25(6):1066–71.CrossRef
24.
go back to reference Bae JM, Choo JY, Kim K-J, Park K-S. Association of inflammatory bowel disease with ankylosing spondylitis and rheumatoid arthritis: a nationwide population-based study. Mod Rheumatol. 2017;27(3):435–40.CrossRef Bae JM, Choo JY, Kim K-J, Park K-S. Association of inflammatory bowel disease with ankylosing spondylitis and rheumatoid arthritis: a nationwide population-based study. Mod Rheumatol. 2017;27(3):435–40.CrossRef
25.
go back to reference Bandinelli F, Manetti M, Ibba-Manneschi L. Occult spondyloarthritis in inflammatory bowel disease. Clin Rheumatol. 2016;35(2):281–9.CrossRef Bandinelli F, Manetti M, Ibba-Manneschi L. Occult spondyloarthritis in inflammatory bowel disease. Clin Rheumatol. 2016;35(2):281–9.CrossRef
Metadata
Title
From bowel inflammation to the bone and joints: musculoskeletal examination in inflammatory bowel disease (IBD)
Authors
Samane Tavassoli
Iman Shahabinasab
Alireza Norouzi
Taghi Amiriani
Nafiseh Abdolahi
Somayeh Livani
Seyed Farzam Mirkamali
Honey Sadat Mirkarimi
Fazel Isapanah Amlashi
Sima Besharat
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2021
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-021-04903-4

Other articles of this Issue 1/2021

BMC Musculoskeletal Disorders 1/2021 Go to the issue